Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2022AtherosclerosisOpen Access

The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMarlys L. KoschinskyFKFlorian Kronenberg

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Koschinsky et al. (2022) studied this question.

synapsesocial.com/papers/6a1bf1a4d54006be995f455dhttps://doi.org/10.1016/j.atherosclerosis.2022.04.017
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease2005 · 787 citations
  2. 2Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population2007 · 556 citations
  3. 3Lipoprotein(a) Reduction in Persons with Cardiovascular Disease2020 · 1,071 citations
  4. 4Mendelian Randomization: Principles and its usage in Lp(a) research2022 · 44 citations
  5. 5Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.1990 · 547 citations